Vaccines News
-
GSK Australia announces regulatory approval of respiratory syncytial virus vaccine AREXVY
Vaccines | News | 0 Comment | 19 Jan, 2024
GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...Read more
-
Zuellig Pharma & Substipharm Biologics expand access to Japanese Encephalitis vaccine across Asia
Vaccines | News | 0 Comment | 16 Jan, 2024
Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...Read more
-
Singapore's Duke-NUS scientists discover potential nasal COVID-19 vaccine candidate
Vaccines | News | 0 Comment | 10 Jan, 2024
A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...Read more
-
CEPI partners with Korean biotech startup Lemonex to advance mRNA vaccine delivery
Vaccines | News | 0 Comment | 05 Jan, 2024
Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...Read more
-
Korea gives license to Euvichol-S, simplified formulation of oral cholera vaccine
Vaccines | News | 0 Comment | 02 Jan, 2024
The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...Read more
-
CEPI and PATH strengthen partnership to accelerate development of vaccines
Vaccines | News | 0 Comment | 19 Dec, 2023
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-based nonprofit global health organisation&nb...Read more
-
Novavax's updated COVID-19 vaccine receives emergency use authorisation in Taiwan
Vaccines | News | 0 Comment | 18 Dec, 2023
American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...Read more
-
Vaccines | News | 0 Comment | 18 Dec, 2023
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...Read more
-
CEPI supports novel mRNA vaccine development in Korea to protect against future Disease X
Vaccines | News | 0 Comment | 12 Dec, 2023
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...Read more
-
DxVx plans clinical trials of cancer vaccine in Asia, including Korea and China
Vaccines | News | 0 Comment | 27 Nov, 2023
South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...Read more
-
Chulalongkorn University in Thailand supports UK-South East Asia vaccine manufacturing research hub
Vaccines | News | 0 Comment | 24 Nov, 2023
Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...Read more
-
Korea accelerates innovations in vaccines and immunology
Vaccines | News | 0 Comment | 23 Nov, 2023
The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...Read more
-
SK bioscience and Hilleman Laboratories to develop Zaire Ebola Virus vaccine
Vaccines | News | 0 Comment | 22 Nov, 2023
South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...Read more
-
Hong Kong Jockey Club Global Health Institute to bolster global preparedness for future pandemics
Vaccines | News | 0 Comment | 17 Nov, 2023
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...Read more
-
New typhoid conjugate vaccine Bio-TCV receives approval in Indonesia
Vaccines | News | 0 Comment | 14 Nov, 2023
South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...Read more
-
US FDA approves first chikungunya vaccine Ixchiq developed by Austria's Valneva
Vaccines | News | 0 Comment | 10 Nov, 2023
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...Read more
-
Hilleman Lab invest $20M to launch new ACES cGMP Facility in Singapore
Vaccines | Company results | 2 Comment | 09 Nov, 2023
On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...Read more
-
UK injects £33 M to develop vaccines for diseases with epidemic potential in LMICs
Vaccines | News | 0 Comment | 09 Nov, 2023
Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...Read more
